Inventor

Zheng Wang

Inventor

Shanghai, CN

Overview

33→

Patents

1996–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 33 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds17%

C07BGeneral methods of organic chemistry14%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%

A61KPreparations for medical, dental or toiletry purposes11%

C07CAcyclic or carbocyclic compounds11%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%

B01DSeparation4%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%

C10GCracking hydrocarbon oils4%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

PatentTitleYear

10,874,674Crystal form of orexin receptor antagonist compound, and preparation method and application thereof2020 10,858,322Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one2020 10,780,091TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms2020 10,745,367Method for preparing formamide compound2020 10,683,296TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses2020 10,668,066Crystal form of orexin receptor antagonist compound, and preparation method and application thereof2020 10,633,347Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one2020 10,479,789Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor2019 10,442,811Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof2019 10,428,073Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof2019 10,399,981Crystal form A of 7-(cyclopropylmethyl)-1-(((2019 10,329,498Two-bed paraffin to olefin enhancement process2019 10,323,046Method for preparing L-BPA2019 10,294,440Catalytic system for preparation of high branched alkane from olefins2019 10,253,030Crystal form, preparation method and intermediate of dihydropyrido ring compound2019 10,227,339Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate2019 10,227,309Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one2019 10,190,156Methods and systems for using built-in standard curve to measure molecular numbers of biological components2019 10,167,241Two-bed paraffin to olefin enhancement process2019 9,816,995'Biomarker for ovarian cancer CTAP3-related proteins'2017 9,527,862'Compounds of chiral aromatic spiroketal diphosphine ligands, preparation methods and uses thereof'2016 9,518,014'Process for synthesis of ezetimibe and intermediates used in said process'2016 9,430,610'Re-sequencing pathogen microarray'2016 9,315,755'Catalytic system for preparation of high branched alkane from olefins'2016 9,156,874'Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs'2015 9,095,599'O-(substituted benzyl) phosphoramidate compounds and therapeutic use'2015 7,668,664'Design and selection of genetic targets for sequence resolved organism detection and identification'2010 6,960,449'Class characterization of circulating cancer cells isolated from body fluids and methods of use'2005 6,800,764'Process for the synthesis of chirally pure beta-amino-alcohols'2004 6,353,126'Process for the production of malononitrile'2002 6,235,944'Production of secondaryalkoxy-1-alkenes'2001 5,962,237'Method of enriching rare cells'1999 5,523,411'Synthesis of mitomycin and its analogs'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2002Patents assigned to CREANOVA INC (2)· patent assignee history

2001–2004Based in East Brunswick, NJ, US· patent location history

2010–2016Based in Burke, VA, US· patent location history

2015–2019Patents assigned to WANG ZHENG (4)· patent assignee history

2015Patents assigned to NANJING MOLECULAR RES INC (2)· patent assignee history

2015Based in Suzhou, CN· patent location history

2016–2020Based in Shanghai, CN· patent location history

2019–2020Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (4)· patent assignee history

2019–2020Patents assigned to SHANDONG DANHONG PHARMACEUTICAL CO LTD (3)· patent assignee history

2019Based in Villa Park, IL, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD	4	2019–2020
WANG ZHENGself	4	2015–2019
SHANDONG DANHONG PHARMACEUTICAL CO LTD	3	2019–2020
CREANOVA INC	2	2001–2002
NANJING MOLECULAR RES INC	2	2015

Locations

Location	Patents	Span
Shanghai, CN	17	2016–2020
East Brunswick, New Jersey, US	3	2001–2004
Villa Park, Illinois, US	2	2019
Burke, Virginia, US	2	2010–2016
Suzhou, CN	2	2015